Patient and Provider Demand for and Readiness to Adopt Medications for Stimulant Use Disorders in Real‐World Settings: Pre‐Planning Toward Accelerated Implementation
Drug and Alcohol Review · 2026
DOI: 10.1111/dar.70247 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug and Alcohol Review, 2026. Verfasst von Enya B Vroom und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Research to Advance Community Health, Long School of Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, …. Hauptthemen laut MEDLINE: Substance-Related Disorders, Central Nervous System Stimulants, Attitude of Health Personnel, Health Personnel. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, National Center for Advancing Translational Sciences (NCATS).
Abstract (Originalsprache)
Introduction
In the United States, rates of stimulant use disorder (StUD) have increased over the last 20 years, yet fewer than one‐third of adults receive treatment. Recent research has shown the efficacy of medication for StUD, but little is known regarding demand and readiness to adopt such treatments. This study examined patient and provider perspectives on medication for StUD in real‐world practice settings.
Methods
Semi‐structured interviews were conducted with patients with substance use disorder (SUD) history ( n = 20) and SUD care team members ( n = 20) currently providing SUD services. Interviews elicited perceptions of treatment demand, barriers/facilitators, and recommendations for future implementation. Rapid qualitative analysis was used to distill and compare findings across groups. Analysis was guided by the Health Equity Implementation Framework (HEIF), selected for its focus on implementation and social determinants.
Results
Consistent with HEIF, multilevel patient and care team barriers and facilitators were identified, reflecting the importance of the clinical encounter and highlighting implementation challenges within the inner, outer and societal contexts, particularly related to stigma. Training for providers and education for patients and families were recommended to overcome stigma. Utilising patient‐centred care approaches and addressing societal factors impacting treatment engagement were also discussed as likely to affect medication access. Discussion and Conclusions Examining patient and care teams' perceptions of medications for StUD improves understanding of demand and readiness for adoption. This information, rooted in lived experiences, provides a foundation for selecting tailored implementation strategies that may assist in accelerating the adoption of medications to treat StUD in future scale‐up and spread.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Research to Advance Community Health, Long School of Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
- Be Well Institute on Substance Use and Related Disorders, Long School of Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
- Department of Medicine, Long School of Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
- Department of Psychiatry and Behavioral Sciences, Long School of Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
- Center for the Study of Healthcare Innovation, Implementation, and Policy, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California, USA.
ORCID-Profile: Enya B Vroom, Jennifer S Potter
Förderung
- NCATS NIH HHS
- National Center for Advancing Translational Sciences (NCATS)
Zitieren
APA
Vroom, E. B., Finley, E. P., Bolton, C. D., Karns-Wright, T., & Potter, J. S. (2026). Patient and Provider Demand for and Readiness to Adopt Medications for Stimulant Use Disorders in Real‐World Settings: Pre‐Planning Toward Accelerated Implementation. Drug and Alcohol Review. https://doi.org/10.1111/dar.70247
Vancouver
Vroom EB, Finley EP, Bolton CD, Karns-Wright T, Potter JS. Patient and Provider Demand for and Readiness to Adopt Medications for Stimulant Use Disorders in Real‐World Settings: Pre‐Planning Toward Accelerated Implementation. Drug and Alcohol Review. 2026. doi:10.1111/dar.70247
BibTeX
@article{Vroom2026,
author = {Vroom, Enya B and Finley, Erin P and Bolton, Carma Deem and Karns-Wright, Tara and Potter, Jennifer S},
title = {Patient and Provider Demand for and Readiness to Adopt Medications for Stimulant Use Disorders in Real‐World Settings: Pre‐Planning Toward Accelerated Implementation},
journal = {Drug and Alcohol Review},
year = {2026},
doi = {10.1111/dar.70247}
}
EUVIMED